Partnervest Advisory Services’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-35,000
Closed -$42K 200
2019
Q4
$42K Buy
+35,000
New +$42K 0.02% 231